ROPES WEALTH ADVISORS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$29,000
+20.8%
2490.0%0.00%
-20.0%
Q3 2020$24,000
-22.6%
2490.0%0.01%
-16.7%
Q2 2020$31,000
+40.9%
2490.0%0.01%0.0%
Q1 2020$22,000
-15.4%
2490.0%0.01%0.0%
Q4 2019$26,000
-10.3%
2490.0%0.01%0.0%
Q3 2019$29,000
-19.4%
249
+19.1%
0.01%
-25.0%
Q2 2019$36,000
+2.9%
2090.0%0.01%
-11.1%
Q1 2019$35,000
+75.0%
2090.0%0.01%
+50.0%
Q4 2018$20,000
+66.7%
209
+202.9%
0.01%
+100.0%
Q3 2018$12,000690.00%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders